An international team of scientists say they have found genetic data that links the origins of the Covid-19 pandemic to raccoon dogs that were sold at a wet market in Wuhan.
, the genetic data in question was extracted from swabs taken from in and around Wuhan’s Huanan Seafood Wholesale Market at the start of the pandemic.
This finding is one of the strongest pieces of genetic evidence linking an animal being sold at the wet market to the coronavirus that caused the pandemic.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Genetic Data Links Covid Origins To Raccoon Dogs Sold At Wuhan Wet MarketThis finding is the first piece of genetic evidence linking an animal being sold at the wet market to the coronavirus that caused the pandemic.
Read more »
Raccoon Dogs Likely Started COVID-19 Pandemic, New Genetic Analysis ShowsA new analysis of samples collected from a Wuhan seafood market has suggested for the first time a concrete link between some of the wild animals being illegally sold there and the origins of the COVID-19 pandemic, The Atlantic reported.
Read more »
Paxlovid not linked to COVID rebound, FDA saysClinical trial data has concluded that there is no clear association with a COVID-19 rebound.
Read more »
Stunning Diversity of Comb Jellies Revealed Through Genetic ProbesComb jellies—known to scientists as ctenophores (pronounced “teen-oh-fours”)—mesmerize with their beauty, but these captivating creatures remain poorly studied due to their delicate nature. MBARI researchers have used the power of genetics to learn more about these animals. In a study published i
Read more »
Seeking Alzheimer's clues from few who escape genetic fateMany members of Doug Whitney’s family developed Alzheimer’s by the unusually young age of 50. Yet the 73-year-old’s mind is still sharp, and scientists are studying how Whitney and other incredibly rare “escapees” may naturally resist the disease.
Read more »
Paxlovid not linked to COVID rebound, FDA saysThe FDA gave the COVID-19 anti-viral emergency use authorization in 2021 for treating mild to moderate illness in high-risk adults.
Read more »